Cardiac Pacemaker

0
Pipeline Programs
1
Companies
8
Clinical Trials
6 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Abbott
AbbottABBOTT PARK, IL
6 programs
AVEIR CSP Leadless Pacemaker SystemN/A1 trial
AVEIR remote care systemN/A1 trial
Aveir AR Leadless PacemakerN/A1 trial
Aveir DR Leadless Pacemaker SystemN/A1 trial
Aveir DR Leadless Pacemaker SystemN/A1 trial
+1 more programs
Active Trials
NCT07287423Recruiting20Est. Dec 2028
NCT06542133Completed32Est. Aug 2024
NCT06100770Recruiting586Est. Jan 2031
+5 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
AbbottAVEIR CSP Leadless Pacemaker System
AbbottAVEIR remote care system
AbbottAveir AR Leadless Pacemaker
AbbottAveir DR Leadless Pacemaker System
AbbottAveir DR Leadless Pacemaker System
AbbottAveir VR Leadless Pacemaker System
AbbottAveir VR Leadless Pacemaker System
AbbottAveir VR Leadless Pacemaker System

Clinical Trials (8)

Total enrollment: 16,425 patients across 8 trials

NCT07287423AbbottAVEIR CSP Leadless Pacemaker System

LEAP 2 Chronic EFS

Start: Dec 2025Est. completion: Dec 202820 patients
N/ARecruiting
NCT06542133AbbottAVEIR remote care system

AVEIR Remote Care System Non-Significant Risk Study

Start: Jun 2024Est. completion: Aug 202432 patients
N/ACompleted
NCT06100770AbbottAveir AR Leadless Pacemaker

Aveir AR Coverage With Evidence Development (CED) Study

Start: Jan 2024Est. completion: Jan 2031586 patients
N/ARecruiting
NCT05932602AbbottAveir DR Leadless Pacemaker System

AVEIR DR Coverage With Evidence Development (CED) Study

Start: Oct 2023Est. completion: May 20302,812 patients
N/ARecruiting
NCT05935007AbbottAveir DR Leadless Pacemaker System

Aveir DR Real-World Evidence Post-Approval Study

Start: Oct 2023Est. completion: Jan 20301,805 patients
N/ARecruiting
NCT05336877AbbottAveir VR Leadless Pacemaker System

Aveir VR Coverage With Evidence Development Post-Approval Study

Start: Jun 2022Est. completion: Jan 20288,744 patients
N/ARecruiting
NCT05270499AbbottAveir VR Leadless Pacemaker System

Aveir VR Real-World Evidence Post-Approval Study

Start: Jun 2022Est. completion: Feb 20342,100 patients
N/ARecruiting
NCT04559945AbbottAveir VR Leadless Pacemaker System

The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System

Start: Nov 2020Est. completion: Aug 2023326 patients
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

6 actively recruiting trials targeting 16,425 patients
1 companies competing in this space